Patents by Inventor Carina Henningsson

Carina Henningsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Enhancement of the cellular immune response
    Patent number: 6582697
    Abstract: DTH-Effector cells are primed with carbohydrate antigens and used to enhance the cellular immune response. Tumors have been inhibited by DTH-Effector cells primed with epiglycanin and with synthetic T and Tn antigens. Either the DTH-Effector cells, or these tumor-associated carbohydrate antigens directly, may be used for tumor prophylaxis and therapy.
    Type: Grant
    Filed: November 7, 2001
    Date of Patent: June 24, 2003
    Assignee: Biomira, Inc.
    Inventors: B. Michael Longenecker, Carina Henningsson
  • Enhancement of the cellular immune response
    Publication number: 20020068071
    Abstract: DTH-Effector cells are primed with carbohydrate antigens and used to enhance the cellular immune response. Tumors have been inhibited by DTH-Effector cells primed with epiglycanin and with synthetic T and Tn antigens. Either the DTH-Effector cells, or these tumor-associated carbohydrate antigens directly, may be used for tumor prophylaxis and therapy.
    Type: Application
    Filed: November 7, 2001
    Publication date: June 6, 2002
    Inventors: B. Michael Longenecker, Carina Henningsson
  • Enhancement of the cellular immune response
    Patent number: 6326009
    Abstract: DTH-Effector cells are primed with carbohydrate antigens and used to enhance the cellular immune response. Tumors have been inhibited by DTH-Effector cells primed with epiglycanin and with synthetic T and Tn antigens. Either the DTH-Effector cells, or these tumor-associated carbohydrate antigens directly, may be used for tumor prophylaxis and therapy.
    Type: Grant
    Filed: February 11, 1998
    Date of Patent: December 4, 2001
    Assignee: Biomira, Inc.
    Inventors: B. Michael Longenecker, Carina Henningsson
  • Enhancement of the cellular immune response
    Patent number: 5798090
    Abstract: DTH-Effector cells are primed with carbohydrate antigens and used to enhance the cellular immune response. Tumors have been inhibited by DTH-Effector cells primed with epiglycanin and with synthetic T and Tn antigens. Either the DTH-Effector cells, or these tumor-associated carbohydrate antigens directly, may be used for tumor prophylaxis and therapy.
    Type: Grant
    Filed: February 24, 1995
    Date of Patent: August 25, 1998
    Assignee: Biomira, Inc.
    Inventors: B. Michael Longenecker, Carina Henningsson
  • Enhancement of the cellular immune response using carbohydrate primed DTH effector cells expressing the CD5+/CD8- phenotype
    Patent number: 4971795
    Abstract: DTH-Effector cells are primed with carbohydrate antigens and used to enhance the cellular immune response. Tumors have been inhibited by DTH-Effector cells primed with epiglycanin and with synthetic T and Tn antigens. Either the DTH-Effector cells, or these tumor-associated carbohydrate antigens directly, may be used for tumor prophylaxis and therapy.
    Type: Grant
    Filed: July 21, 1988
    Date of Patent: November 20, 1990
    Assignee: Biomira, Inc.
    Inventors: B. Michael Longenecker, Carina Henningsson
  • Enhancement of the cellular immune response
    Patent number: RE38046
    Abstract: DTH-Effector cells are printed with carbohydrate antigens and used to enhance the cellular immune response. Tumors have been inhibited by DTH-Effector cells primed with epiglycanin and with synthetic T and Tn antigens. Either the DTH-Effector cells, or these tumor-associated carbohydrate antigens directly, may be used for tumor prophylaxis and therapy.
    Type: Grant
    Filed: August 25, 2000
    Date of Patent: March 25, 2003
    Assignee: Biomira, Inc.
    Inventors: B. Michael Longenecker, Carina Henningsson